전신성 활동불능증(Systemic Exertion Intolerance Disease) 진단 기준을 바탕으로 한 만성 피로 증후군(Chronic Fatigue Syndrome) 진단 설문지 개발 및 신뢰도 평가
Development and Validation of Questionnaire for Chronic Fatigue Syndrome (CFS) Diagnosis Based on Systemic Exertion Intolerance Disease (SEID) Criteria
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: This study aimed to develop a questionnaire for the diagnosis of chronic fatigue syndrome (CFS) designed based on the systematic exertion intolerance disorder (SEID) criteria, and to validate the reliability of the questionnaire. Methods: A literature search on questionnaires for CFS diagnosis was conducted to develop a SEID questionnaire (SEID-Q27), followed by a pilot survey to identify the reliability of the questionnaire. Adults (Daejeon university personnel) with a Chalder fatigue scale (CFQ) score ≥15 were invited for the survey. We commenced the survey in November 2019 with a two weeks of interval for the test and retest method. The reliability of the questionnaire was investigated in three angles: 1. Cronbach’s α, 2. correlations (r) of the questions, numerical rating scale (NRS), and visual analog scale (VAS), and 3. kappa (k) analysis. Results: Among the total 275 adults registered, 55 (20%) participants with a CFQ score ≥15 were invited, and 31 (11%) [15 male, 16 female] completed the questionnaire. The total Cronbach’s α was 0.944 for the test and 0.949 for the retest. The reliability (r) of questions by CFQ score (≥15, ≥18, ≥20) ranged from 0.533–0.928 (p <0.05), and the r score of the NRS and VAS were the highest in CFQ scores ≥20, at 0.933 (p<0.001). The agreement rate of the SEID-Q27 between the test and retest was 87% (kappa k=0.743). Conclusions: The SEID-Q27 seems to be reliable. Further studies are needed to measure the validity of the tool and the cutoff point.
Abstract
Purpose: This study aimed to develop a questionnaire for the diagnosis of chronic fatigue syndrome (CFS) designed based on the systematic exertion intolerance disorder (SEID) criteria, and to validate the reliability of the questionnaire. Methods: A literature search on questionnaires for CFS diagnosis was conducted to develop a SEID questionnaire (SEID-Q27), followed by a pilot survey to identify the reliability of the questionnaire. Adults (Daejeon university personnel) with a Chalder fatigue scale (CFQ) score ≥15 were invited for the survey. We commenced the survey in November 2019 with a two weeks of interval for the test and retest method. The reliability of the questionnaire was investigated in three angles: 1. Cronbach’s α, 2. correlations (r) of the questions, numerical rating scale (NRS), and visual analog scale (VAS), and 3. kappa (k) analysis. Results: Among the total 275 adults registered, 55 (20%) participants with a CFQ score ≥15 were invited, and 31 (11%) [15 male, 16 female] completed the questionnaire. The total Cronbach’s α was 0.944 for the test and 0.949 for the retest. The reliability (r) of questions by CFQ score (≥15, ≥18, ≥20) ranged from 0.533–0.928 (p <0.05), and the r score of the NRS and VAS were the highest in CFQ scores ≥20, at 0.933 (p<0.001). The agreement rate of the SEID-Q27 between the test and retest was 87% (kappa k=0.743). Conclusions: The SEID-Q27 seems to be reliable. Further studies are needed to measure the validity of the tool and the cutoff point.
참고문헌 (21)
- Institute of Medicine, "Beyond Myalgic Encephalomyelitis", Chronic Fatigue Syndrome:Redefining an Illness. The National Academies of Sciences Engineering Medicine, 2015
- Hawk C, "Torres-Harding S. Reliability of a chronic fatigue syndrome Questionnaire", Journal of Chronic Fatigue Syndrome, 13(4), pp.41~66 (2006)
- Shin HC, "Overview of chronic fatigue syndrome for primary care physicians", Journal of Korean Family Medicine, 22(12), pp.1717~1742 (2001)
- Nacul LC, "Prevalence of myalgic encephalomyelitis", chronic fatigue syndrome (ME, BioMed Central Medicine, pp.2011, 9[DOI]
- Speight N, "Myalgic encephalomyelitis", chronic fatigue syndrome : Review of history, clinical features, and controversies, 2013, pp.1(1), 11~13
- Christley Y, "A review or the definitional criteria for chronic fatigue syndrome", Journal of Evaluation in Clinical Practice, 18(1), pp.25~31 (2012)
- Morris G, "Case definitions and diagnostic criteria for Myalgic Encephalomyelitis and Chronic fatigue syndrome:from clinical-consensus to evidence-based case definitions", Act Nerv Super Rediviva, 55(1-2), pp.64~78 (2013)
- Johnston S, "The adoption of chronic fatigue syndrome", myalgic encephalomyelitis case definitions to assess prevalence:a systematic review, 2013, pp.23(6), 371~376
- 최종후, "Poll from the beginning to the end 2013", pp.77~78, 자유아카데미
- Chalder T, "Development of a fatigue scale", J Psychosom Res, 37(2), pp.147~153 (1993)
- Cella M, "Measuring fatigue in clinical and community settings", J Psychosom Res, 69(1), pp.17~22 (2010)
- 정준호, "만성피로증후군 환자의 질환경험과 고통의 사회화", 보건과 사회과학, (42), pp.5~38 (2016), 한국보건사회학회
- Haney E, "Diagnostic Methods for Myalgic Encephalomyelitis", Chronic fatigue syndrome:A systematic review for a National institute of health pathways to prevention workshop, 2015, pp.162(12), 834~840
- Jason LA, "Test-Retest Reliability of the DePaul Symptom Questionnaire", Fatigue, 3(1), pp.16~32 (2015)
- Dijkers MP, "Reporting on reliability and validity of outcome measures in medical rehabilitation research", Disabil Rehabil, 24(16), pp.819~827 (2002)
- Nijs J, "The Chronic Fatigue Syndrome Activities and Participation Questionnaire (CFS-APQ):an overview", Occup Ther Int, 12(2), pp.107~721 (2005)
- Hyde B, "Are myalgic encephalomyelitis and chronic fatigue syndrome synonymous?", They Syndrome Sentinel, 3, pp.5~8 (1999)
- Vaes JP, "Psychometric properties of the Dutch Chronic Fatigue Syndrome-Activities and Participation Questionnaire(CFS-APQ)", Phys Ther, 83(5), pp.444~454 (2003)
- Jason LA, "Fatigue Scales and Chronic Fatigue Syndrome : Issues of Sensitivity and Specificity", Disabil Stud Q, 31(1), pp.1375~ (2011)
- Lim EJ, "Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome", myalgic encephalomyelitis (CFS, J Translational Medicine, pp.2020, 18(1)[DOI]